Commenced in January 2007
Paper Count: 30308
Contrast-Enhanced Magnetic Resonance Angiography in Rats with Gadobenate Dimeglumine at 3T
Abstract:This study aimed to investigate the magnetic resonance (MR) signal enhancement ratio (ER) of contrast-enhanced MR angiography (CE-MRA) in normal rats with gadobenate dimeglumine (Gd-BOPTA) using a clinical 3T scanner and an extremity coil. The relaxivities of Gd-BOPTA with saline only and with 4.5% human serum albumin (HSA) were also measured. Compared with Gadolinium diethylenetriaminepentaacetic acid (Gd-DTPA), Gd-BOPTA had higher relaxivities. The maximum ER of aorta (ERa), kidney, liver and muscle with Gd-BOPTA were higher than those with Gd-DTPA. The maximum ERa appeared at 1.2 min and decayed to half at 10 min after Gd-BOPTA injection. This information is helpful for the design of CE-MRA study of rats.
Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1106881Procedia APA BibTeX Chicago EndNote Harvard JSON MLA RIS XML ISO 690 PDF Downloads 1391
 A. Levent, I. Yuce, S. Eren, O. Ozyigit, and M. Kantarci, “Contrast-Enhanced and Time-of-Flight MR Angiographic Assessment of Endovascular Coiled Intracranial Aneurysms at 1.5 T,” Interv Neuroradiol., vol. 20, pp. 686-92, Dec 2014.
 S. Roujol, M. Foppa, T.A. Basha, M. Akçakaya, K.V. Kissinger, B. Goddu, S. Berg, and R. Nezafat, “Accelerated free breathing ECG triggered contrast enhanced pulmonary vein magnetic resonance angiography using compressed sensing,” J Cardiovasc Magn Reson., vol. 16, pp. 91, Nov 2014.
 S. Mavrogeni, G. Markousis-Mavrogenis, and G. Kolovou, “Contribution of cardiovascular magnetic resonance in the evaluation of coronary arteries,” World J Cardiol., vol. 6, pp. 1060-6, Oct 2014.
 X. Mu, H. Wang, Q. Ma, C. Wu, and L. Ma, “Contrast-enhanced magnetic resonance angiography for the preoperative evaluation of hepatic vascular anatomy in living liver donors: a meta-analysis,” Acad Radiol., vol. 21, pp. 743-9, Jun 2014.
 A. M. Saindane, S. R. Boddu, F. C. Tong, S. Dehkharghani, and J. E. Dion, “Contrast-enhanced time-resolved MRA for pre-angiographic evaluation of suspected spinal dural arterial venous fistulas,” J Neurointerv Surg., vol. 7, pp. 135-40, Feb. 2015.
 H. P. Niendorf, J. C. Dinger, J. Haustein, I. Cornelius, A. Alhassan, W. Clauss, “Tolerance data of Gd-DTPA: a review,”Eur J Radiol., Vol. 13, pp. 15-21, Jul-Aug 1991.
 M. A. Kirchin, G. P. Pirovano, A. Spinazzi, “Gadobenatedimeglumine (Gd-BOPTA). An overview,” Invest Radiol., Vol. 33, pp. 798-809, Nov. 1998.
 K. Yoshikawa, Y. Inoue, M. Shimada, M. Akahane, S. Itoh, A. Seno, S. Hayashi., “Contrast-enhanced MRangiography in rats with hepatobiliary contrast agents,”Magn Reson Imaging., Vol. 22, pp. 937-42, Sep. 2004.
 E. M. Haacke, R. W. Brwon, M. R. Thompson, R. Venkatesan, Magnetic Resonance Imaging: Physical Principles and Sequence Design, New York, NY: John Wiley and Sons Inc, 1999, pp. 128.
 J. C. Jao, H.C. Lu, H. Y. Lu, Y. M. Wang, G.C. Liu, L. M. Lin, P. Y. Chu, S..H. Chen, P. C. Chen, “The Imaging Behavior of an MRI Contrast Agent (Gd(TTDA-BOM)2- in a Mice Liver Model at 3 Tesla,” J Med Biol Eng., Vol. 30, pp. 139-144, Jun 2010.
 X. Xing, X. Zeng, X. Li, Q. Zhao, M.A. Kirchin, G. Pirovano, X. Wang, Y. Li, R. Iezzi, and F. De Cobelli, “Contrast-enhanced MR angiography: does a higher relaxivity MR contrast agent permit a reduction of the dose administered for routine vascular imaging applications?,”Radiol Med., vol. 120, pp. 239-50, Feb 2015.
 K.L. Nguyen, S.N. Khan, J.M. Moriarty, K. Mohajer, P. Renella, G. Satou, I. Ayad, S. Patel, M.I. Boechat, and J.P. Finn, “High-field MR imaging in pediatric congenital heart disease: initial results,” PediatrRadiol., vol. 45(1), pp. 42-54, Jan 2015.
 S. Gaddikeri, L. Mitsumori, S. Vaidya, D.S. Hippe, P. Bhargava, and M.K. Dighe, “Comparing the diagnostic accuracy of contrast-enhanced computed tomographic angiography and gadolinium-enhancedmagnetic resonance angiography for the assessment of hemodynamically significant transplant renal artery stenosis,” CurrProblDiagnRadiol., vol. 43, pp. 162-8, Jul. 2014.